Medpace Core Laboratories is Pleased to Announce A Successfully Completed Inspection by the FDA

April 7, 2020

Medpace Core Laboratories successfully completed a comprehensive inspection by the FDA on a late phase, registrational, oncology trial. The inspection concluded with no major or minor findings, reflecting the high quality and systematic execution of the trial by MCL.

Read More